News for Healthier Living

Clinical Trial Shows Positive Results of Enhanced CAR T-Cell Therapy for Patients with B-Cell Blood Cancers

* Results from a phase I clinical trial show enhanced chimeric antigen receptor (CAR) T-cell therapy improved outcomes for patients with B-cell blood cancers. * Building on their previous work, researchers tested targeting three proteins and used another protein to boost immune response in patients. * Data showed better outcomes for patients who have limited options after their B-cell blood cancer returned or previous therapy stopped working.

October 13, 2026


October 14 2026

October 13 2026

October 12 2026

October 11 2026

October 10 2026

October 9 2026

October 8 2026

October 7 2026

October 6 2026

October 5 2026

October 2 2026

October 1 2026

September 30 2026